Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Single and multiple dose pharmacokinetics of a new NSAID (droxicam) in healthy volunteers.

Martinez L, Sanchez J, Roser R, Garcia-Barbal J, Sagarra R, Bartlett A.

Eur J Drug Metab Pharmacokinet. 1989 Oct-Dec;14(4):303-7.

PMID:
2633925
2.

Pharmacokinetic profile of droxicam.

Martínez L, Sánchez J.

Eur J Rheumatol Inflamm. 1991;11(4):10-4. Review.

PMID:
1365484
3.

Cross-over study of the bioavailability of a new NSAID (droxicam) versus piroxicam in healthy volunteers following single and multiple dose administration.

Bartlett A, Costa A, Martinez L, Roser R, Sagarra R, Sanchez J.

Eur J Drug Metab Pharmacokinet. 1992 Jul-Sep;17(3):195-9.

PMID:
1490488
4.

Comparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) versus piroxicam in healthy volunteers.

Martínez L, Sánchez J, Roser R, García-Barbal J, Bartlett A, Estruch J, Sagarra R, Puig S, Costa A.

Methods Find Exp Clin Pharmacol. 1988 Nov;10(11):729-37.

PMID:
3221746
5.

A comparative bioavailability study to estimate the influence of an antacid on droxicam pharmacokinetics.

Maya MT, Pais JP, Ruas Da Silva J, Morais JA.

Eur J Drug Metab Pharmacokinet. 1995 Oct-Dec;20(4):275-9.

PMID:
8983932
6.

The effect of antacid and ranitidine on droxicam pharmacokinetics.

Bartlett A, Costa A, Martínez L, Roser R, Sagarra R, Sánchez J.

J Clin Pharmacol. 1992 Dec;32(12):1115-9.

PMID:
1487550
7.

The influence of gastric emptying on droxicam pharmacokinetics.

Sánchez J, Martínez L, García-Barbal J, Roser R, Bartlett A, Sagarra R.

J Clin Pharmacol. 1989 Aug;29(8):739-45.

PMID:
2778095
8.

Pharmacokinetics of orally administered single- and multiple-dose olopatadine in healthy Chinese subjects: an open-label study.

Chu NN, Chen WL, Xu HR, Li XN.

Clin Drug Investig. 2009;29(7):451-7. doi: 10.2165/00044011-200929070-00003.

PMID:
19499962
9.

A pharmacokinetic study to evaluate the profile of droxicam in elderly healthy volunteers after a single oral dose of 20mg.

Hosie J, Kelly J, Sánchez J, Bartlett A, Harrison FJ.

Eur J Rheumatol Inflamm. 1991;11(4):45-9.

PMID:
1365490
10.

Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of protein-binding differences on steady-state pharmacokinetics.

Karim A, Noveck R, McMahon FG, Smith M, Crosby S, Adams M, Wilton J.

J Clin Pharmacol. 1997 Apr;37(4):267-78.

PMID:
9115051
11.

Plasma tenoxicam concentrations after single and multiple oral doses.

Crevoisier C, Heizmann P, Forgo I, Dubach UC.

Eur J Drug Metab Pharmacokinet. 1989 Jan-Mar;14(1):23-7.

PMID:
2788089
12.

Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor.

Moore KH, Cass LM, Dallow N, Hardman TC, Jones A, Boyce M, Prince WT.

Eur J Clin Pharmacol. 2001 Jan-Feb;56(11):805-11.

PMID:
11294370
13.

Bioavailability and pharmacokinetics of ibuprofen in the broiler chicken.

Roder JD, Chen CL, Chen H, Sangiah S.

J Vet Pharmacol Ther. 1996 Jun;19(3):200-4.

PMID:
8803878
14.
15.

Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.

Fornasini G, Monti N, Brogin G, Gallina M, Eandi M, Persiani S, Bani M, Della Pepa C, Zara G, Strolin Benedetti M.

Chirality. 1997;9(3):297-302.

PMID:
9176996
16.

Pharmacokinetics of droxicam in rat and dog.

Esteve A, Martínez L, Roser R, Sagarra R.

Methods Find Exp Clin Pharmacol. 1986 Jul;8(7):423-9.

PMID:
3762266
17.

Single dose pharmacokinetics of piroxicam in cats.

Heeb HL, Chun R, Koch DE, Goatley MA, Hunter RP.

J Vet Pharmacol Ther. 2003 Aug;26(4):259-63.

PMID:
12887607
18.

Pharmacokinetics and bioavailability of percutaneous ibuprofen.

Kleinbloesem CH, Ouwerkerk M, Spitznagel W, Wilkinson FE, Kaiser RR.

Arzneimittelforschung. 1995 Oct;45(10):1117-21.

PMID:
8595072
19.

Pharmacokinetics and tolerability of meloxicam after i.m. administration.

Narjes H, Türck D, Busch U, Heinzel G, Nehmiz G.

Br J Clin Pharmacol. 1996 Feb;41(2):135-9.

20.

A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.

Marcelín-Jiménez G, Angeles-Moreno AP, Contreras-Zavala L, Morales-Martínez M, Rivera-Espinosa L.

Clin Ther. 2009 Sep;31(9):2002-11. doi: 10.1016/j.clinthera.2009.09.016.

PMID:
19843490
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk